Autopsy report · NCT01910870

Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes

“Because of difficulties in recruiting”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 3 years 2 months before it stopped.
• 4 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Centre Jean Perrin

Sponsor type

University, hospital or other

Conditions

Metastatic Breast Cancer

Interventions

Cisplatin; Metronomic Cyclophosphamide

Participants

4

Sites

1

Countries

France

Trials that died the same way

• The SOLID Platelet Study
  “Due to recruitment difficulty” (85% match in meaning)
• Seropositivity and Adverse Birth Events in Migrants From Bilharzia-endemic Areas
  “due to lack of recruitment” (84% match in meaning)
• REALIB-LLA-2017: Idelalisib in Patients With Acute Lymphoblastic Leukemia
  “Because of low recruitment” (81% match in meaning)
• The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin
  “Due to recruitment issues.” (81% match in meaning)
• Robotic Therapy and Transcranial Direct Current Stimulation in Patients With Stroke
  “Because of low recruitment rates” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.